Latest article
Fierce Pharma Asia—AstraZeneca-Junshi PD-1 deal; Takeda’s $1.2B diabetes selloff, Ovid epilepsy collab pullout
In a strangely structured deal, AstraZeneca has nationwide licensed Junshi Biosciences' PD-1 inhibitor for only one indication in China. Takeda continued to sell...
Aromatherapy Diffusers Market Present and Future Pattern 2021 with High Keyplayers – Vitruvi US...
Aromatherapy Diffusers Market 2021
This newly added report from Straits Research Aromatherapy Diffusers Market Presents an analysis of the market situation and challenges. Experts...
Health Facilities, Out of doors Areas and Models All Turning into Bigger, Say Seniors...
Pictured from left to right are David Kliewer from Grandbridge Real Estate Capital, Michael Hartman from Capitol Seniors Housing, Scott Gensler from Erickson...